Prelude Capital Management’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-11,901
Closed -$235K – 1194
2025
Q4
$235K Sell
11,901
-13,429
-53% -$241K 0.02% 943
2025
Q3
$442K Buy
25,330
+14,959
+144% +$222K 0.03% 536
2025
Q2
$145K Buy
+10,371
New +$167K 0.01% 863
2024
Q2
– Sell
-10,900
Closed -$54.1K – 1198
2024
Q1
$54.1K Buy
+10,900
New +$69.8K ﹤0.01% 1253

Other funds holding ALHC

Prelude Capital Management's ALHC Position: Q1 2026 in Review

Prelude Capital Management sold out of Alignment Healthcare (ALHC) in Q1 2026, closing a stake of 11,901 shares — an estimated $235K sold.

Prelude Capital Management first reported a position in ALHC in Q1 2024 and held it in 4 quarters. The position peaked at $442K in Q3 2025. 293 funds tracked by Wall St. Rank hold ALHC as of Q1 2026.

  • Prelude Capital Management reported no remaining Alignment Healthcare position as of Q1 2026 after selling out during the quarter.
  • Prelude Capital Management sold 11,901 Alignment Healthcare shares in Q1 2026, an estimated $235K.
  • Prelude Capital Management first reported a position in Alignment Healthcare in Q1 2024 and held it in 4 quarters.
  • Prelude Capital Management's Alignment Healthcare position peaked at $442K in Q3 2025.
  • 293 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.